All News

FDA Update: FDA timeline for revision of the labels for TOFA, BARI, UPA - all needing to add a boxed warning on CV and cancer risk - This could take 2-3 mos- This is why youre still waiting.. #ACR21 https://t.co/DfJWWYuUQh
Dr. John Cush RheumNow ( View Tweet)
FDA Safety Update on JAK Inhibitors - bottom line on the Tofactitinib Post-Marketing (PMR) study published Sept 1st (cancer higher rates of lung CA and lymphoma with both doses of Tofa vs TNFi) #ACR21 https://t.co/UGbiTGVpgW
Dr. John Cush RheumNow ( View Tweet)

GOSH and NAC pedi CAPS pts study since 2005: anti-IL1 treatment has major impact on prevention and tx of CAPS symptoms. Observed by improved CAPS clinical dz activity scores; and normalized inflammatory markers. Abs 1110 #ACR21 #RheumNow @RheumNow https://t.co/xXrnVeRAq5

Links:

Dr. Rachel Tate uptoTate ( View Tweet)

ASAS PerSpA study findings: rheumatologists tended to dx IBD-SpA in pts w peripheral arthritis more commonly than axial symptoms. IBD predominantly presenting symptoms. Abs 1310 #ACR21 #RheumNow @RheumNow https://t.co/Gq1b5gXn0v https://t.co/oZRvwvgbJD

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Abstr 1313 Lee & Colleagues used clustering analysis to study impact of comorbidities in patients with #axSpA - Comorbidities can influence treatment outcomes and should be accounted for in when treating #axSpA #ACR21 @RheumNow https://t.co/rN7LPQ9qEk
Akhil Sood MD AkhilSoodMD ( View Tweet)
Clinical Pearl from Dr. @JKolfenbach: ⭐️(-) ANCA doesn't r/o limited GPA ⭐️Biopsies can be just as important for ruling out mimics: ‣Neoplastic Dx (NK/T cell sinus lymphomas) ‣Histiocytic process ‣Infectious (fungal, mycobacteria) ‣Foreign material (cocaine) #ACR21 @RheumNow https://t.co/PEoYPBFLj0
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
#Precisionmedicine is here but we’re not using it? A 23 molecular signature response classifier (MSRC) identified pts w RA unlikely to respond to #TNFi. no response was<ACR50 over 1yr. 175 w 26⬆️MSRC & 47 ⬆️⬆️MSRC. If ⬇️MSRC29%<ACR50 v 42&60%. ?cost Abst#1252 #ACR21 @RheumNow https://t.co/xdYyN0oXrh
Janet Pope Janetbirdope ( View Tweet)
Abst1100 #ACR2021 @RheumNow PAH in AOSD rare, mostly in polycyclic disease, associated w/flares (85%). overall survival 93% at 1 year and 74% at 3 years. PAH was severe at diagnosis: 2 (15%), 7 (54%) and 4 (31%) patients were in NYHA functional class II, III and IV, respectively. https://t.co/x20LooA2G7
Olga Petryna DrPetryna ( View Tweet)
Always thought⬆️health care access in Canada would lead to⬆️utilization of arthroplasty also rich-poor differences would be lower due to universal health access. Our study Canada Vs US and says otherwise!! Rich-poor differences are📈 greater in Canada! @rheumnow #abst1037 #ACR21 https://t.co/wKHXpsgSJn
Bella Mehta bella_mehta ( View Tweet)
While outcomes didn't worsen, de novo PsO can occur at any time point in axSpA (results per 6 year, DESIR cohort study.) Regular follow ups are key to monitoring. Abs 1311 #ACR21 #RheumNow #ACRbest @RheumNow https://t.co/X1bot5UJ6Q https://t.co/qfbDhCT9q5

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Well, this just got fun. Let's follow this, blow by blow in this thread. @US_FDA session #ACR21 @RheumNow https://t.co/3GCRfsINgn
David Liew drdavidliew ( View Tweet)
Abstr 1317 Impact of Memory in #axSpA Compared to healthy controls, patients with #axSpA performed significantly worse on Memory and Attention Test (MAT) specifically in working memory and selective attention #ACR21 @RheumNow https://t.co/PJS2QroKOS
Akhil Sood MD AkhilSoodMD ( View Tweet)
Why do pts get #RheumatoidArthritis & also #psoriatic in same jts? Also #psoriasis recurs in same spots. Memory cells, altered permeability of cell membranes? Dunno but neat study shows early RA jt involvement likes to recur in same jts. But can spread! @RheumNow #ACR21 abst#1216 https://t.co/qCORzfhjqH

Links:

Janet Pope Janetbirdope ( View Tweet)

MSK Ultrasound demonstrated continued improvement of synovitis and enthesitis in PsA pts on secukinumab. ⭐️continued improvement of GLOESS (synovitis) and OMERACT enthesitis score at 52 weeks Abs#1360 #ACR21 @RheumNow https://t.co/ISVZrXkEiI https://t.co/dXlfi3R962

Links:

Robert B Chao, MD doctorRBC ( View Tweet)
Routine evaluation of MRE and MRI in Crohn's Disease could be a way to detect axSpa. 25% of 48 CD patients had abnormal SI joint finding, majority asymptomatic, female, and had stricturing or penetrating CD @RheumNow #ACR21 Abst#1306 #ACRBest https://t.co/MYMV3UDGck https://t.co/p9fov02OdH

Links:

Dr. Antoni Chan synovialjoints ( View Tweet)
What matters for PsA pts & MDs? In this study, pts and MDs in consensus w/#arthritis dse activity, fatigue & pain as impt aspects of PsA care; but disparities still exist👇 MDs-clinical Pts-access to care, sleep Communication is🔑➡shared decision making @RheumNow #ACR21 abs1165 https://t.co/Zd4r47OMGx
sheila RHEUMarampa ( View Tweet)
A clever hack for those who have difficulty with public speaking! I would add breathe to this list! Janet Zeide presents "RHEUM" during The Gift of Gab at #ACR21 @RheumNow https://t.co/fjAFZDiao5
Dr. Rachel Tate uptoTate ( View Tweet)
A retrospective cohort study demonstrates a statistically and clinically significant lower risk for developing PsA among patients with psoriasis that receive biologic medications Abst #1355 #ACR21 @RheumNow https://t.co/OK20VKO82f
swethaann23 swethaann23 ( View Tweet)
@SattuiSEMD on frailty in PMR. High prevalence frailty (12-17%) and pre-frailty (54-59%). Frailty associated worse HRQoL. Abstr#1392 #ACR21 @RheumNow https://t.co/Y2evVHrrTa
Richard Conway RichardPAConway ( View Tweet)
#ACR21 Opening Day Recap: Drs. Cush, Dao ( @KDAO2011) , Tate ( @uptotate) and Reyes ( @RHEUMarampa ) https://t.co/v0DH4jY84v https://t.co/oflVOkzSie

Links:

Dr. John Cush RheumNow ( View Tweet)
×